Qingdao Vland Biotech Co Ltd (603739) — Cash Flow-to-Debt Ratio
Qingdao Vland Biotech Co Ltd (603739) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥24.29 Million could theoretically repay 0% of its total liabilities (CN¥1.14 Billion) in one year. See 603739 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qingdao Vland Biotech Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Qingdao Vland Biotech Co Ltd across 11 annual periods. Also explore Qingdao Vland Biotech Co Ltd (603739) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Qingdao Vland Biotech Co Ltd. For market capitalisation and broader financial context, see how much is Qingdao Vland Biotech Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥195.41 Million | CN¥1.11 Billion | ▲ +38.4% |
| 2023 | 0.13x | CN¥153.59 Million | CN¥1.21 Billion | ▲ +12.7% |
| 2022 | 0.11x | CN¥95.31 Million | CN¥844.93 Million | ▼ -32.4% |
| 2021 | 0.17x | CN¥89.51 Million | CN¥536.18 Million | ▼ -67.6% |
| 2020 | 0.51x | CN¥173.00 Million | CN¥336.22 Million | ▲ +96.1% |
| 2019 | 0.26x | CN¥65.33 Million | CN¥248.99 Million | ▼ -3.9% |
| 2018 | 0.27x | CN¥85.75 Million | CN¥313.94 Million | ▼ -34.8% |
| 2017 | 0.42x | CN¥121.90 Million | CN¥291.02 Million | ▼ -26.8% |
| 2016 | 0.57x | CN¥154.49 Million | CN¥269.96 Million | ▲ +132.9% |
| 2015 | 0.25x | CN¥74.27 Million | CN¥302.27 Million | ▲ +37.9% |
| 2014 | 0.18x | CN¥58.55 Million | CN¥328.53 Million | — |